Iovance Biotherapeutics, Inc. demonstrates improved Q4 results, with $87M revenue and a 50% gross margin. Learn more about IOVA stock here.
Bank of America preferreds, BAC.PR.Q and BAC.PR.N, are rated BBB-, are non-cumulative, and qualify for the 15% tax rate. Read ...
With the benefit of attracting BHP Xplor into our organisation, we’re looking to longer-term exploration potential in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results